Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $20

Benzinga · 06/06 10:42
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $19 to $20.